FDA fronts pivotal life sciences trend in 2020
How the FDA's modernization plan will change the regulatory landscape and the resulting trends that will impact public health
Add bookmark
As the US Food and Drug Administration (FDA) moves its IT systems to the cloud, this whitepaper from MasterControl details how the transformation will impact the life sciences industry.
With the life sciences industry experiencing a surge of scientific and technology advances, a sizeable gap between the innovations and the technologies exist, creating a disconnect that harms the translation of solutions into useful therapies.
This whitepaper addresses how the FDA plans to close that gap by fostering modernization in life sciences as it transforms its own technology infrastructure.
Share best practice, ideas, and solutions to our global community of more than 125,000 senior pharmaceutical and biotech professionals. View our latest Media Kit to learn more about our audience and review our content calendar. Download NowInterested in presenting your own Case Study?
Download this whitepaper to discover:
- Industry trends that will have the most favorable impact on public health.
- How the FDA's modernization plan will change the regulatory landscape.
- How digital technologies are transforming the life sciences industry.
